Participating clinicians should begin the application process now.
The Centers for Medicare and Medicaid Services (CMS) has announced that it is accepting the impact of COVID-19 as a condition for applying for an Extreme and Uncontrollable Circumstances exemption in the Merit-based Incentive Payment System (MIPS).
For the 2020 performance year (PY), Medicare will be using its Extreme and Uncontrollable Circumstances policy to allow clinicians, groups, and virtual groups to submit an application requesting reweighting of one or more MIPS performance categories due to the current COVID-19 public health emergency. To provide additional support to clinicians, the agency is extending the extreme and uncontrollable circumstances application deadline for PY 2020 to Monday, February 1, 2021 at 8 p.m. ET.
Join ASN for New Approaches to Transform Outcomes for Kidney Disease and Heart Disease in Patients with Diabetes, a videoconference scheduled for Thursday, December 10, from 4:00 – 5:30 PM EST.
International clinical experts will review the latest guidelines for both kidney disease and cardiovascular disease, and discuss the most recent clinical trials and promising therapies, including the groundbreaking use of SGLT2 inhibitors to reduce morbidity and mortality. These are among the first new therapies demonstrated to help prevent the development of heart disease and reduce progression of kidney disease in people with T2DM.
Kidney research and treatment is undergoing tremendous, positive change. Part of that change is propelled by the cutting-edge work funded by KidneyCure. Over 24 years, ASN, and now KidneyCure, has awarded over $53 million to advance kidney health by funding studies of excellence. The researchers performing this work have propelled a sea change of advances that are helping create a world without kidney diseases.
Final rule applies new standards to organ procurement in the U.S.
The U.S. Department of Health and Human Services (HHS) today took action to increase donation rates and organ transplantation rates by applying new standards of accountability and transparency to the nation’s Organ Procurement Organizations (OPOs). HHS finalized the Organ Procurement Organizations Conditions for Coverage: Revisions to the Outcome Measure Requirements for Organ Procurement Organization rule that was proposed earlier this year by the Centers for Medicare and Medicaid Services (CMS).
The United States Renal Data System released its 2020 Annual Data Report, featuring the latest data accumulated through 2018. This report, funded by the National Institute of Diabetes and Digestive Kidney Diseases, provides an overview of the impact of kidney disease on the US population. The annual report developed by the USRDS serves as an invaluable resource for ASN and the kidney community in determining policy priorities and advocacy efforts. In addition to familiar findings health outcomes and health care spending related to kidney disease and kidney failure, the 2020 Annual Data Report reviews the impact of COVID-19 on kidney patients.
Nearly 50% of US nephrologists are graduates of international medical schools . These individuals provide critical care in our nation’s teaching hospitals and in areas facing critical physician shortages, fight the COVID-19 pandemic on the front lines, and conduct pioneering research in labs across the country.
The American Society of Nephrology (ASN) condemns baseless claims that physicians and hospitals are overcounting or inflating the number of deaths due to the COVID-19 pandemic. People with kidney failure are the most vulnerable patients to COVID-19 in the entire Medicare population.
On behalf of our society, I thank each one of you for your unwavering commitment to improving kidney health throughout the world. This first-ever Kidney Week Reimagined symbolizes many of the opportunities and challenges nephrology faces. Your participation during these unparalleled and supremely challenging times is so highly valued and greatly appreciated.
The American Society of Nephrology (ASN) is proud to announce the upcoming launch of the ASN Loan Mitigation Pilot Program.
This exciting program will launch in early 2021, and the pilot will continue for three years. ASN has committed $2,700,000 to reaching those who are considering nephrology as a career.
In the first year of the pilot, ASN will fund six applicants, reducing the loan burden for each applicant by $50,000 over three years. Year 1 awards will center on individuals racially underrepresented in medicine. When the program launches, ASN will disseminate details regarding eligibility requirements and the application process.
Health professionals take great pride in our commitment to improving the lives of those we care for. We recognize and accept that our calling involves risk, day in and day out.
This year, facing the challenges, stress, and ongoing burden of a global pandemic, kidney professionals have demonstrated the resolve and focus on excellence that exemplifies our profession.
Physicians, scientists, nurses, advanced practice providers, technicians, and so many others have stepped into unknown territory with grace and courage. We have devised new ways to provide care, taken on additional work with resolve, and shared essential knowledge and insights with peers worldwide.